Mia's Feed
Medical News & Research

Using Voice-Activated Devices to Screen for Parkinson's Disease

Using Voice-Activated Devices to Screen for Parkinson's Disease

Share this article

A new AI-powered speech analysis tool using Amazon Alexa and Google Home offers a promising way to screen for Parkinson's disease in accessible, remote settings, achieving up to 86% accuracy.

2 min read

Researchers at the University of Rochester have developed an innovative, AI-driven speech-based tool that could assist in early detection of Parkinson's disease, the second most common neurodegenerative disorder worldwide. This web-based screening method leverages popular voice-activated assistants like Amazon Alexa and Google Home, potentially enabling wider access in remote or underserved areas.

The system operates by asking users to recite two pangrams—specific phrases that utilize all 26 alphabet letters. These voice recordings are then analyzed by advanced AI models trained on millions of audio samples to identify subtle speech patterns associated with Parkinson's. The analysis achieved an impressive accuracy of nearly 86%, highlighting its potential as a preliminary screening tool.

Currently, Parkinson's diagnosis relies on neurologists assessing motor symptoms and conducting neurological exams, often supported by imaging techniques. While this AI tool is not a substitute for a clinical diagnosis, it offers a quick, accessible way for individuals to assess their risk and encourages them to seek medical evaluation if needed.

To validate the approach, data was collected from over 1,300 participants across diverse settings, including home environments and clinical visits. Participants read aloud two sentences—"The quick brown fox jumps over the lazy dog" and a longer descriptive sentence—while their speech was recorded and analyzed.

The AI models focus on speech characteristics such as speech rate, pauses, breathing patterns, and articulation, which can differ in people with Parkinson's. As speech impairments are present in approximately 89% of cases, analyzing vocal cues provides a promising starting point for digital screening.

The researchers emphasize that combining speech analysis with other symptom assessments, like facial expressions and motor tasks, can improve screening accuracy and coverage. An interactive demo of these screening tools is available online.

This technology aims to bridge the gap in neurological care access, especially in remote areas, by utilizing ubiquitous voice assistants to identify individuals who may need further medical evaluation. The study's findings, published in "npj Parkinson's Disease," showcase the potential of integrating AI and speech analysis for early detection and monitoring of Parkinson's disease.

For more details, see the full study: source.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Blinking Exercise App Developed by Optometrist to Alleviate Dry Eye Symptoms

Discover how a new app and optimized blinking exercises developed by an Aston University expert can effectively reduce dry eye symptoms and improve eye comfort with just a few minutes daily.

Implantable Cardioverter Defibrillators Show No Mortality Benefit in Certain Heart Attack Patients

New research at ESC 2025 suggests that implantable cardioverter defibrillators may not reduce mortality in certain post-heart attack patients with moderate LV dysfunction and arrhythmia risk markers.

Potential Medicaid Reductions Could Unfairly Impact Older Workers and Their Well-being

Proposed Medicaid cuts threaten to disproportionately affect older workers by imposing strict work requirements that could lead to significant health coverage losses, according to recent research.

Innovative Strategies in Pediatric Brain Cancer Treatment: Focused Therapies and Advanced Delivery Techniques

Virginia Tech researchers are developing precise targeted therapies and advanced delivery techniques to improve treatment outcomes for pediatric brain cancer, especially glioblastoma. Using focused ultrasound to enhance drug delivery and targeting specific proteins like KAT6A may revolutionize future therapies.